Related Experiment Video
Updated: Jul 8, 2026
09:44
Neuro-rehabilitation Approach for Sudden Sensorineural Hearing Loss
Published on: January 25, 2016
19.1K
A Pharmacist's Reflection on the Symposium's OTC Hearing Aid Implementation Panel
1American Pharmacists Association, Washington, District of Columbia.
Seminars in Hearing
|April 28, 2025
Summary
Over-the-counter (OTC) hearing aid sales offer various implementation models. A symposium panel discussed pharmacist, audiologist, and consumer perspectives, highlighting the need for interprofessional collaboration.
Area of Science:
- Audiology
- Pharmacy Practice
- Consumer Health
Background:
- The advent of over-the-counter (OTC) hearing aids presents new avenues for accessibility.
- Understanding the diverse implementation strategies for OTC hearing aids is crucial for stakeholders.
- Previous research has not fully captured the multifaceted considerations from various professional and consumer viewpoints.
Purpose of the Study:
- To explore the varied implementation models for OTC hearing aid sales.
- To synthesize perspectives from pharmacists, audiologists, and consumers regarding OTC hearing aid access.
- To emphasize the importance of interprofessional collaboration in the successful integration of OTC hearing aids.
Main Methods:
- A panel discussion at the OTC Hearing Aid and Self-Care Symposium.
- Expert insights were gathered from representatives of pharmacy, audiology, and consumer advocacy.
- The article is authored by the panel moderator, providing a synthesized overview.
Main Results:
- Multiple implementation pathways for OTC hearing aids exist, each with unique challenges and benefits.
- Key considerations for successful implementation include professional roles, patient support, and regulatory frameworks.
- Pharmacists, audiologists, and consumers share distinct but interconnected concerns regarding OTC hearing aid accessibility and utilization.
Conclusions:
- Successful implementation of OTC hearing aids necessitates a collaborative approach among healthcare professionals and informed consumers.
- Interprofessional collaboration is vital to address potential barriers and optimize patient outcomes in the OTC hearing aid market.
- Further dialogue and strategy development are needed to ensure equitable and effective access to hearing healthcare solutions.
Related Concept Videos
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:02Prescription, Nonprescription and Orphan Drugs
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
01:26Drug Administration and Therapy Phases: Overview
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
01:24Dosage Regimen: Individualization
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
01:23Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...